Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)
- PMID: 21677690
- PMCID: PMC3382196
- DOI: 10.1038/gt.2011.87
Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)
Abstract
Coagulation factor X (FX)-binding ablated adenovirus type 5 (Ad5) vectors have been genetically engineered to ablate the interaction with FX, resulting in substantially reduced hepatocyte transduction following intravenous administration in rodents. Here, we quantify viral genomes and gene transfer mediated by Ad5 and FX-binding-ablated Ad5 vectors in non-human primates. Ad5 vectors accumulated in and mediated gene transfer predominantly to the liver, whereas FX-binding-ablated vectors primarily targeted the spleen but showed negligible liver gene transfer. In addition, we show that Ad5 binding to hepatocytes may be due to the presence of heparan sulfate proteoglycans (HSPGs) on the cell membrane. Therefore, the Ad5-FX-HSPG pathway mediating liver gene transfer in rodents is also the mechanism underlying Ad5 hepatocyte transduction in Microcebus murinus.
Figures



Similar articles
-
Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.PLoS Pathog. 2010 Oct 7;6(10):e1001142. doi: 10.1371/journal.ppat.1001142. PLoS Pathog. 2010. PMID: 20949078 Free PMC article.
-
A cluster of basic amino acids in the factor X serine protease mediates surface attachment of adenovirus/FX complexes.J Virol. 2011 Oct;85(20):10914-9. doi: 10.1128/JVI.05382-11. Epub 2011 Aug 17. J Virol. 2011. PMID: 21849463 Free PMC article.
-
Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.J Virol. 2015 Oct 21;90(1):412-20. doi: 10.1128/JVI.01939-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26491162 Free PMC article.
-
The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery.Expert Opin Drug Deliv. 2014 Nov;11(11):1795-813. doi: 10.1517/17425247.2014.938637. Epub 2014 Jul 18. Expert Opin Drug Deliv. 2014. PMID: 25036189 Review.
-
Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction.Curr Gene Ther. 2009 Apr;9(2):115-27. doi: 10.2174/156652309787909544. Curr Gene Ther. 2009. PMID: 19355869 Review.
Cited by
-
Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells.J Virol. 2011 Dec;85(24):13420-31. doi: 10.1128/JVI.06088-11. Epub 2011 Oct 5. J Virol. 2011. PMID: 21976659 Free PMC article.
-
Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.Mol Cancer. 2012 May 8;11:31. doi: 10.1186/1476-4598-11-31. Mol Cancer. 2012. PMID: 22569271 Free PMC article.
-
Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts.PLoS One. 2013 Sep 2;8(9):e73650. doi: 10.1371/journal.pone.0073650. eCollection 2013. PLoS One. 2013. PMID: 24023896 Free PMC article.
-
Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.Biomedicines. 2014 Apr 2;2(2):132-148. doi: 10.3390/biomedicines2020132. Biomedicines. 2014. PMID: 28548064 Free PMC article. Review.
-
FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment.Mol Ther. 2023 Oct 4;31(10):2914-2928. doi: 10.1016/j.ymthe.2023.08.018. Epub 2023 Aug 28. Mol Ther. 2023. PMID: 37641405 Free PMC article.
References
-
- Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, Nicklin SA, van Rooijen N, Custers J, Goudsmit J, Barouch DH, McVey JH, Baker AH. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood. 2009;114:965–71. - PMC - PubMed
-
- Hamid O, Varterasian ML, Wadler S, Hecht JR, Benson A, 3rd, Galanis E, Uprichard M, Omer C, Bycott P, Hackman RC, Shields AF. Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer. J Clin Oncol. 2003;21:1498–504. - PubMed
-
- Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genetics. 1992;1:372–378. - PubMed